Nardella Flore

A drug repurposing screen identifies altiratinib as a selective inhibitor of a key regulatory splicing kinase and a potential therapeutic for toxoplasmosis and malaria

A. Bougdour, C. Mas, Y. Couté, 2021 .

Altiratinib blocks Toxoplasma gondii and Plasmodium falciparum development by selectively targeting a spliceosome kinase

A. Bougdour, C. Mas, Y. Couté, 2022, Science Translational Medicine.